If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,310.00    10.00 (0.16%)
Bid:
6,310.00
Ask:
6,320.00
Spread: 10.00 (0.158%)
Market Cap: £4.66b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Spirax Sarco to start direct operations in India

5 Mar 2015 07:01

RNS Number : 5806G
Spirax-Sarco Engineering PLC
05 March 2015
 

 

News Release 

5th March 2015

 

Spirax Sarco to start direct operations in India and exit joint venture  

Spirax-Sarco Engineering plc, the world leader in the control and efficient use of steam and in niche fluid technology, announces the establishment of a new wholly-owned operation through which it will commence direct selling into the Indian market, which has good medium and long-term opportunities for sales and profit growth. An agreement has also been signed on 1st March 2015 to exit the long-standing joint venture in India with Forbes Marshall Private Limited, with completion expected before the 31st March 2015.

 

Our new Indian management team are completing the preparatory actions of the last twelve months to start direct sales operations in India by mid-2015 through our new wholly-owned company Spirax-Sarco India Private Ltd. We will also be accelerating our investment to rapidly establish world class local manufacturing and training facilities at our recently purchased site in Chennai. We had a 49.3% interest in the Associate Company in India, Spirax Marshall Private Limited, which had been in operation since 1959 under the management control of our local partners. We have sold our interest in this joint venture to our former partners in India, at tangible asset value, for £6.5m in cash. The agreement also provides for both parties to trade inside and outside India under their respective names, while we retain exclusive rights to Spirax Sarco's brands and product nomenclature.

 

In the twelve month period ended 31st December 2014, the Group's 49.3% share of the adjusted after-tax profit of the Associate Company was £1.3m, having declined 32% from £1.9m in 2013. Over the last four years, profit contribution from this Associate Company has shown a steady decline to below 1% of the Group's pre-tax profits. We expect that our new operation will make a small negative contribution to earnings in 2015, as the business builds both sales and manufacturing activities, but with an increasing contribution thereafter. In the Group's 2014 accounts, this investment in Associate is designated as an asset held for sale. The 2014 statutory profit includes an impairment charge of £1.0m largely in relation to goodwill that arose in 2007 when the Group increased its shareholding from 40.0% to 49.3%.

 

In 2015, on completion of the sale of our 49.3% interest, there will also be a charge to statutory profit, which we currently estimate to be £1.7m, in respect of prior years' balance sheet translation exchange differences that, under IAS 21, are required to be recycled through the Profit & Loss account. Neither the 2014 nor the 2015 adjustments affects cash and neither are included within our reported adjusted profits.

 

Nicholas Anderson, commenting on the agreement, said "We have had a long association in India but the time has come to address the Indian market directly with our own wholly-owned business, which will create the flexibility required to take advantage of the good medium and long-term growth prospects for this developing economy."

 

 

Enquiries:

Nick Anderson, Chief Executive

David Meredith, Director Finance

Tel: 01242 535234

 

 

About Spirax Sarco

Spirax-Sarco Engineering plc is the world leader in both steam system management and niche peristaltic pumps and associated fluid path technologies. The Company provides a broad range of fluid control products, engineered packages, site services and systems expertise for its diverse range of over 100,000 industrial and institutional customers. The Company helps its customers to optimise production capacity, reduce energy costs and emissions, improve product quality and enhance the safety of their operations. Spirax Sarco is headquartered in Cheltenham, England, has strategically located manufacturing plants around the world and employs approximately 4,700 people, of whom around 1,300 are direct sales and service engineers. Its shares have been listed on the London Stock Exchange since 1959 (symbol: SPX). Further information can be found at www.spiraxsarcoengineering.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBRGDXGUGBGUS
Date   Source Headline
8th Jul 20267:00 amRNSDirector/PDMR Shareholding
24th Jun 202611:18 amRNSChange in Major Shareholding
18th Jun 20267:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
8th Jun 20261:24 pmRNSDirector/PDMR Shareholding
1st Jun 202610:28 amRNSChange in Major Shareholding
29th May 20262:24 pmRNSUpdate on Directorships held by Company Directors
27th May 20263:30 pmRNSDirector/PDMR Shareholding
26th May 20265:24 pmRNSDirector/PDMR Shareholding
19th May 20269:16 amRNSChange in Major Shareholding
14th May 20262:47 pmRNSExternal Directorships held by Company Directors
14th May 202610:39 amRNSDirector/PDMR Shareholding
13th May 20264:12 pmRNSResult of AGM
13th May 20267:00 amRNSTrading Update
8th May 20263:42 pmRNSChange in Major Shareholding
7th May 20269:03 amRNSDirector/PDMR Shareholding
8th Apr 20262:22 pmRNSDirector/PDMR Shareholding
8th Apr 20269:30 amRNSAnnual Report and Accounts 2025 and Notice of AGM
18th Mar 20264:53 pmRNSDirector/PDMR Shareholding
11th Mar 20261:53 pmRNSTotal Voting Rights
10th Mar 20265:01 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNS2025 Full Year Results
10th Mar 20267:00 amRNS2025 Full Year Results
9th Mar 20263:35 pmRNSDirector/PDMR Shareholding
9th Mar 20263:35 pmRNSDirector/PDMR Shareholding
10th Feb 20269:30 amRNSChange in Director Details
6th Feb 20263:47 pmRNSDirector/PDMR Shareholding
2nd Feb 20261:50 pmRNSChange in Director Details
30th Jan 20262:19 pmRNSHolding(s) in Company
6th Jan 20263:10 pmRNSDirector/PDMR Shareholding
18th Dec 20252:12 pmRNSCorrection: Block Listing Application
18th Dec 20252:12 pmRNSCorrection: Block Listing Application
18th Dec 202510:34 amRNSBlocklisting Application
9th Dec 20252:35 pmRNSDirector/PDMR Shareholding
18th Nov 20259:40 amRNSDirector/PDMR Shareholding
13th Nov 20257:00 amRNSTrading Update
7th Nov 20251:56 pmRNSDirector/PDMR Shareholding
5th Nov 20258:39 amRNSHolding(s) in Company
22nd Oct 20257:00 amRNSBoard Appointment
7th Oct 20255:08 pmRNSDirector/PDMR Shareholding
9th Sep 20257:00 amRNSDirector/PDMR Shareholding
1st Sep 20259:35 amRNSHolding(s) in Company
12th Aug 20257:00 amRNSBoard Committee Membership Update
12th Aug 20257:00 amRNS2025 Half Year Results
7th Aug 20257:00 amRNSDirector/PDMR Shareholding
24th Jul 20254:58 pmRNSDirector/PDMR Shareholding
9th Jul 20254:26 pmRNSDirector/PDMR Shareholding
13th Jun 20253:36 pmRNSDirector/PDMR Shareholding
14th May 20254:48 pmRNSResult of AGM
14th May 20257:00 amRNSTrading Update
8th May 202511:03 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.